| scholarly article | Q13442814 |
| P2093 | author name string | Kenichi Sugihara | |
| Hiroyuki Uetake | |||
| Masamichi Yasuno | |||
| Masayuki Enomoto | |||
| Satoru Iida | |||
| Tetsuro Higuchi | |||
| Yoko Takagi | |||
| Megumi Ishiguro | |||
| Labile Togba Soumaoro | |||
| P2860 | cites work | Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells | Q24643373 |
| 5-Lipoxygenase and leukotriene B(4) receptor are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue | Q24685466 | ||
| Licofelone--clinical update on a novel LOX/COX inhibitor for the treatment of osteoarthritis | Q28167018 | ||
| A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer | Q28195274 | ||
| Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas | Q28201753 | ||
| Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice | Q28513001 | ||
| The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis | Q29616121 | ||
| Lipoxygenase-5 is overexpressed in prostate adenocarcinoma | Q32159450 | ||
| Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. | Q33193757 | ||
| Lipoxygenase inhibitors prevent urological cancer cell growth | Q33201090 | ||
| Lipoxygenase inhibitors as potential cancer chemopreventives | Q33647970 | ||
| Prognostic value of ERM gene expression in human primary breast cancers | Q34366259 | ||
| Increased 5-lipoxygenase expression and induction of apoptosis by its inhibitors in esophageal cancer: a potential target for prevention. | Q34386488 | ||
| Many actions of cyclooxygenase-2 in cellular dynamics and in cancer | Q34539982 | ||
| New trends in dual 5-LOX/COX inhibition | Q34609294 | ||
| Mammalian lipoxygenases: molecular structures and functions | Q35460975 | ||
| Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy | Q35575515 | ||
| The role of prostaglandins and other eicosanoids in the gastrointestinal tract | Q36123763 | ||
| Selective COX-2 inhibitors and risk of myocardial infarction | Q36173750 | ||
| 5-lipoxygenase regulates malignant mesothelial cell survival: involvement of vascular endothelial growth factor. | Q40771073 | ||
| Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. | Q40925773 | ||
| Expression of 15-lipoxygenase-1 in human colorectal cancer. | Q40976706 | ||
| 5-Lipoxygenase, a marker for early pancreatic intraepithelial neoplastic lesions | Q42812216 | ||
| Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions. | Q43711880 | ||
| Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma | Q44955215 | ||
| Contributory role of 5-lipoxygenase and its association with angiogenesis in the promotion of inflammation-associated colonic tumorigenesis by cigarette smoking. | Q45055873 | ||
| Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis | Q45099333 | ||
| Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma | Q45159535 | ||
| Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke. | Q45214752 | ||
| Overexpression of 5-lipoxygenase and cyclooxygenase 2 in hamster and human oral cancer and chemopreventive effects of zileuton and celecoxib | Q46365845 | ||
| Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer | Q46506011 | ||
| Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. | Q53362101 | ||
| Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. | Q53423897 | ||
| Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia | Q73028655 | ||
| Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma | Q73862914 | ||
| Cyclooxygenase-1 and -2 in human testicular tumours | Q73904955 | ||
| Phase I and pharmacokinetic study of LY293111, an orally bioavailable LTB4 receptor antagonist, in patients with advanced solid tumors | Q81820052 | ||
| P433 | issue | 39 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 6355-6360 | |
| P577 | publication date | 2006-10-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Expression of 5-lipoxygenase in human colorectal cancer | |
| P478 | volume | 12 |
| Q35989598 | Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction |
| Q37744787 | Bisindolylmaleimide alkaloid BMA-155Cl induces autophagy and apoptosis in human hepatocarcinoma HepG-2 cells through the NF-κB p65 pathway |
| Q42940308 | Cancer chemoprevention by 7-prenyloxycoumarins: a role for 5-lipoxygenase inhibition? |
| Q35597223 | Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention |
| Q42423787 | Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells |
| Q28308101 | Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer |
| Q26778011 | Eicosanoid pathway in colorectal cancer: Recent updates |
| Q88956170 | Eicosanoid signaling in carcinogenesis of colorectal cancer |
| Q55412981 | Expression profile of NF-κB regulated genes in sporadic colorectal cancer patients. |
| Q34121447 | Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk |
| Q33855839 | Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancer |
| Q40046039 | Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade |
| Q28658683 | Methyl jasmonate: putative mechanisms of action on cancer cells cycle, metabolism, and apoptosis |
| Q48274748 | MiR-216a-3p inhibits colorectal cancer cell proliferation through direct targeting COX-2 and ALOX5. |
| Q48136191 | Molecular profiling and genome-wide analysis based on somatic copy number alterations in advanced colorectal cancers |
| Q49383041 | Molecular signature of nitric oxide on major cancer hallmarks of colorectal carcinoma |
| Q51370636 | Overexpression of 5-lipoxygenase and its relation with cell proliferation and angiogenesis in 7,12-dimethylbenz(α)anthracene-induced rat mammary carcinogenesis. |
| Q34030871 | Overexpression of 5-lipoxygenase in sporadic colonic adenomas and a possible new aspect of colon carcinogenesis. |
| Q35529214 | Phase II study of the effects of ginger root extract on eicosanoids in colon mucosa in people at normal risk for colorectal cancer |
| Q34401631 | Pilot clinical study of the effects of ginger root extract on eicosanoids in colonic mucosa of subjects at increased risk for colorectal cancer |
| Q24629893 | Polyunsaturated fatty acid metabolism in prostate cancer |
| Q33583930 | ROS-mediated autophagy induced by dysregulation of lipid metabolism plays a protective role in colorectal cancer cells treated with gambogic acid |
| Q63314665 | Role of Lipoxygenases in Pathogenesis of Cancer |
| Q41852993 | Study of the polymorphisms of cyclooxygenase-2 (-765G>C) and 5-lipoxygenase (1708G>A) in patients with colorectal cancer |
| Q58558257 | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway |
Search more.